US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Innovator IBD 50 ETF

34.88

-0.3697-1.05%

Post-market: 34.63-0.2453-0.70%17:03 EDT

Volume:5K

Turnover:160.21K

Market Cap:80.21M

PE:- -

High:34.94

Open:34.65

Low:34.61

Close:35.25

52wk High:44.08

52wk Low:31.61

Shares:2.30M

Float Shares:2.30M

Volume Ratio:0.60

T/O Rate:0.20%

Dividend:0.47

Dividend Rate:1.35%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Analysts Offer Insights on Healthcare Companies: Travere Therapeutics (TVTX), Maze Therapeutics, Inc. (MAZE) and Immunome (IMNM)

Vertiv Earnings Call Signals Powerful AI-Led Growth

AnaptysBio Shareholders Back Board, Governance and Incentives

Credo Brands Unveils Investor Presentation on Q1 FY27 Unaudited Results

MUFTI Posts Modest Q1 Revenue Growth Amid Margin Pressure, Accelerates Premium Push

Do Fabrinet’s (FN) Mixed Earnings Signals Clarify or Cloud Its Long-Term Growth Narrative?

Simply Wall St.

Vertiv Holdings: Volatile Week Masks Powerful AI Story

Applied Digital Corporation Slides Despite Aggressive AI Expansion

Vertiv Holdings Price Target Announced at $381.00/Share by GLJ Research

Major Insider Move at Applied Digital Signals High-Stakes Shift

Travere Therapeutics is Maintained at Outperform by Wedbush

Wedbush Sticks to Their Buy Rating for Travere Therapeutics (TVTX)

Regulatory Uncertainty Threatens Travere Therapeutics’ Cross-Border Deals and Partnerships

Does FILSPARI-Driven Revenue Growth And Wider Losses Change The Bull Case For Travere Therapeutics (TVTX)?

Simply Wall St.

Travere Therapeutics is Maintained at Outperform by Evercore ISI Group

Sterling Infrastructure is Maintained at Overweight by Keybanc

Vertiv Holdings Co's (NYSE:VRT) Earnings May Just Be The Starting Point

Simply Wall St.

Travere Therapeutics price target raised to $62 from $43 at Stifel

Travere Therapeutics (TVTX) Stock Rallies Over 13% After Hours: Here's What Is Going On

Benzinga Earnings

Travere Therapeutics Q2 Adj. EPS $(0.10) Beats $(0.14) Estimate, Sales $169.584M Beat $159.589M Estimate

Benzinga Earnings

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrzen.com/stock/FFTY/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"FFTY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FFTY\",,,,,undefined,":{"symbol":"FFTY","market":"US","secType":"STK","nameCN":"Innovator IBD 50 ETF","latestPrice":34.8753,"timestamp":1789416000000,"preClose":35.245,"halted":0,"volume":4601,"hourTrading":{"tag":"盘后","latestPrice":34.63,"preClose":34.8753,"latestTime":"17:03 EDT","volume":40,"amount":1387.6425199999999,"timestamp":1789419828747,"change":-0.2453,"changeRate":-0.007034,"amplitude":0.007034},"delay":0,"changeRate":-0.010489431124982114,"floatShares":2300000,"shares":2300000,"eps":0,"marketStatus":"Post-Mkt","change":-0.3697,"latestTime":"09-14 18:49:58 EDT","open":34.65,"high":34.935,"low":34.61,"amount":160206.58995,"amplitude":0.009221,"askPrice":38.24,"askSize":100,"bidPrice":31.58,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1789430400000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":35.245,"sharesOutstanding":2350000,"nav":35.18,"aum":68601000,"dividendRate":0.013477,"bidAskSpread":0.003382,"preHourTrading":{"tag":"盘前","latestPrice":34.78,"preClose":35.245,"latestTime":"09:21 EDT","volume":15,"amount":513.9,"timestamp":1789392084965,"change":-0.465,"changeRate":-0.013193,"amplitude":0.022131},"postHourTrading":{"tag":"盘后","latestPrice":34.63,"preClose":34.8753,"latestTime":"17:03 EDT","volume":40,"amount":1387.6425199999999,"timestamp":1789419828747,"change":-0.2453,"changeRate":-0.007034,"amplitude":0.007034},"volumeRatio":0.599463,"impliedVol":0.0739,"impliedVolPercentile":0.008},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FFTY\",,,,,undefined,":{"symbol":"FFTY","floatShares":2300000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.599463,"shares":2300000,"dividePrice":0.47,"high":34.935,"amplitude":0.009221,"preClose":35.245,"low":34.61,"week52Low":31.61,"pbRate":"--","week52High":44.08,"institutionHeld":0,"latestPrice":34.8753,"eps":0,"divideRate":0.013477,"volume":4601,"delay":0,"ttmEps":0,"open":34.65,"prevYearClose":34.81,"prevWeekClose":35.245,"prevMonthClose":36.228,"prevQuarterClose":43.55,"fiveDayClose":36.28,"twentyDayClose":37.79,"sixtyDayClose":41.58},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FFTY\",params:#limit:5,,,undefined,":[{"date":"2025-12-31","symbol":"FFTY","amount":0.46895289,"announcedDate":"2025-12-30","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-31","defaultRemindTime":1767191400000,"name":"Innovator IBD 50 ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-01-02","payableDate":"2025-12-31","currency":"USD","dateTimestamp":1767157200000,"payDate":"2026-01-02"},{"date":"2024-12-31","symbol":"FFTY","amount":0.25908,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-31","defaultRemindTime":1735655400000,"name":"Innovator IBD 50 ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-01-02","payableDate":"2024-12-31","currency":"USD","dateTimestamp":1735621200000,"payDate":"2025-01-02"},{"date":"2023-12-28","symbol":"FFTY","amount":0.155289,"announcedDate":"2023-12-27","type":"dividend","market":"US","newRecordDate":"2023-12-29","defaultRemindTime":1703773800000,"name":"Innovator IBD 50 ETF","recordDate":"2024-01-02","payableDate":"2023-12-29","currency":"USD","dateTimestamp":1703739600000,"payDate":"2024-01-02"},{"date":"2023-10-26","symbol":"FFTY","amount":0.00214,"announcedDate":"2023-10-25","type":"dividend","market":"US","newRecordDate":"2023-10-27","defaultRemindTime":1698327000000,"name":"Innovator IBD 50 ETF","recordDate":"2023-10-30","payableDate":"2023-10-27","currency":"USD","dateTimestamp":1698292800000,"payDate":"2023-10-30"},{"market":"US","date":"2022-12-29","symbol":"FFTY","amount":0.600327,"defaultRemindTime":1672324200000,"name":"Innovator IBD 50 ETF","recordDate":"2023-01-03","payableDate":"2022-12-30","currency":"USD","type":"dividend","dateTimestamp":1672290000000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FFTY\",market:\"US\",,,undefined,":[{"executeDate":"2021-12-30","recordDate":"2021-12-31","paymentDate":"2022-01-03","value":0.0991471,"currency":"USD"},{"executeDate":"2022-12-29","recordDate":"2022-12-30","paymentDate":"2023-01-03","value":0.600327,"currency":"USD"},{"executeDate":"2023-10-26","recordDate":"2023-10-27","paymentDate":"2023-10-30","value":0.00214,"currency":"USD"},{"executeDate":"2023-12-28","recordDate":"2023-12-29","paymentDate":"2024-01-02","value":0.155289,"currency":"USD"},{"executeDate":"2024-12-31","recordDate":"2024-12-31","paymentDate":"2025-01-02","value":0.25908,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"FFTY\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"FFTY\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2658974286","title":"Analysts Offer Insights on Healthcare Companies: Travere Therapeutics (TVTX), Maze Therapeutics, Inc. (MAZE) and Immunome (IMNM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658974286","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658974286?lang=en_us&edition=fundamental","pubTime":"2026-08-12 19:40","pubTimestamp":1786534824,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Travere Therapeutics (TVTX), Maze Therapeutics, Inc....","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-travere-therapeutics-tvtx-maze-therapeutics-inc-maze-and-immunome-imnm-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-travere-therapeutics-tvtx-maze-therapeutics-inc-maze-and-immunome-imnm-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LABU","LU0128526141.USD","BK4007","BK4585","HCSG","IMNM","LFSC","XBI","BK4581","BK4563","TVTX","XLV","MAZE","BK4588","LU0029874061.USD","FFTY","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658648944","title":"Vertiv Earnings Call Signals Powerful AI-Led Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2658648944","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658648944?lang=en_us&edition=fundamental","pubTime":"2026-08-12 08:22","pubTimestamp":1786494162,"startTime":"0","endTime":"0","summary":"Vertiv Holdings Co (($VRT)) has held its Q2 earnings call. Read on for the main highlights of the call. Vertiv Holdings Co struck an upbeat tone in...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vertiv-earnings-call-signals-powerful-ai-led-growth?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vertiv-earnings-call-signals-powerful-ai-led-growth?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AGIX","FFTY","CHAT","AIPO","VTHR","QTOC","ARTY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658636945","title":"AnaptysBio Shareholders Back Board, Governance and Incentives","url":"https://stock-news.laohu8.com/highlight/detail?id=2658636945","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658636945?lang=en_us&edition=fundamental","pubTime":"2026-08-12 04:36","pubTimestamp":1786480613,"startTime":"0","endTime":"0","summary":"AnaptysBio ( ($ANAB) ) just unveiled an announcement. On August 11, 2026, AnaptysBio, Inc. held its 2026 Annual Meeting of Stockholders, where shar...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/anaptysbio-shareholders-back-board-governance-and-incentives?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/anaptysbio-shareholders-back-board-governance-and-incentives?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FFTY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658916758","title":"Credo Brands Unveils Investor Presentation on Q1 FY27 Unaudited Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2658916758","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658916758?lang=en_us&edition=fundamental","pubTime":"2026-08-11 22:22","pubTimestamp":1786458142,"startTime":"0","endTime":"0","summary":"Credo Brands Marketing Limited ( ($IN:MUFTI) ) just unveiled an update. Credo Brands Marketing Limited has released an investor presentation detail...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/credo-brands-unveils-investor-presentation-on-q1-fy27-unaudited-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/credo-brands-unveils-investor-presentation-on-q1-fy27-unaudited-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FFTY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658916711","title":"MUFTI Posts Modest Q1 Revenue Growth Amid Margin Pressure, Accelerates Premium Push","url":"https://stock-news.laohu8.com/highlight/detail?id=2658916711","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658916711?lang=en_us&edition=fundamental","pubTime":"2026-08-11 22:21","pubTimestamp":1786458098,"startTime":"0","endTime":"0","summary":"Credo Brands Marketing Limited ( ($IN:MUFTI) ) just unveiled an announcement. Credo Brands Marketing Limited (MUFTI) reported unaudited results for...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/mufti-posts-modest-q1-revenue-growth-amid-margin-pressure-accelerates-premium-push?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/mufti-posts-modest-q1-revenue-growth-amid-margin-pressure-accelerates-premium-push?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FFTY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658631499","title":"Do Fabrinet’s (FN) Mixed Earnings Signals Clarify or Cloud Its Long-Term Growth Narrative?","url":"https://stock-news.laohu8.com/highlight/detail?id=2658631499","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658631499?lang=en_us&edition=fundamental","pubTime":"2026-08-11 08:37","pubTimestamp":1786408664,"startTime":"0","endTime":"0","summary":"In the past week, Fabrinet drew attention ahead of its June 2026 quarter results, with analysts expecting higher year-over-year earnings supported by revenue growth and a slightly positive Earnings ESP. \nThe mixed signal of an earnings beat indicator alongside a Zacks Rank of #4 highlights investor uncertainty over how the upcoming report may align with consensus expectations.\nWe’ll now examine how anticipation of a potentially stronger June-quarter earnings report interacts with Fabrinet’s...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/8132000-choice2-main-header/1585186832476","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/8132000-choice2-main-header/1585186832476"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/tech/nyse-fn/fabrinet/news/do-fabrinets-fn-mixed-earnings-signals-clarify-or-cloud-its","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/tech/nyse-fn/fabrinet/news/do-fabrinets-fn-mixed-earnings-signals-clarify-or-cloud-its","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["FFTY","FN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657785026","title":"Vertiv Holdings: Volatile Week Masks Powerful AI Story","url":"https://stock-news.laohu8.com/highlight/detail?id=2657785026","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657785026?lang=en_us&edition=fundamental","pubTime":"2026-08-08 22:01","pubTimestamp":1786197695,"startTime":"0","endTime":"0","summary":"Vertiv Holdings ( ($VRT) ) has fallen by -8.17%. Read on to learn why. Vertiv Holdings shares have had a choppy week, ultimately finishing down abo...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/weekend-updates/vertiv-holdings-volatile-week-masks-powerful-ai-story?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/weekend-updates/vertiv-holdings-volatile-week-masks-powerful-ai-story?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ARTY","CHAT","QTOC","AIPO","VTHR","AGIX","FFTY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657506678","title":"Applied Digital Corporation Slides Despite Aggressive AI Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2657506678","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657506678?lang=en_us&edition=fundamental","pubTime":"2026-08-08 22:01","pubTimestamp":1786197681,"startTime":"0","endTime":"0","summary":"Applied Digital Corporation ( ($APLD) ) has fallen by -7.12%. Read on to learn why. Applied Digital Corporation shares fell 7.12% over the past wee...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/weekend-updates/applied-digital-corporation-slides-despite-aggressive-ai-expansion?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/weekend-updates/applied-digital-corporation-slides-despite-aggressive-ai-expansion?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AIPO","QTOC","DAPP","AGIX","FFTY","ARTY","CHAT","VTHR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657628040","title":"Vertiv Holdings Price Target Announced at $381.00/Share by GLJ Research","url":"https://stock-news.laohu8.com/highlight/detail?id=2657628040","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657628040?lang=en_us&edition=fundamental","pubTime":"2026-08-08 02:10","pubTimestamp":1786126200,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/VRT/analyst-ratings","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FFTY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657698868","title":"Major Insider Move at Applied Digital Signals High-Stakes Shift","url":"https://stock-news.laohu8.com/highlight/detail?id=2657698868","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657698868?lang=en_us&edition=fundamental","pubTime":"2026-08-07 10:09","pubTimestamp":1786068572,"startTime":"0","endTime":"0","summary":"New insider activity at Applied Digital Corporation ( ($APLD) ) has taken place on August 6, 2026. Director Richard Nottenburg of Applied Digital C...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/major-insider-move-at-applied-digital-signals-high-stakes-shift-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/major-insider-move-at-applied-digital-signals-high-stakes-shift-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FFTY","DAPP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657965537","title":"Travere Therapeutics is Maintained at Outperform by Wedbush","url":"https://stock-news.laohu8.com/highlight/detail?id=2657965537","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657965537?lang=en_us&edition=fundamental","pubTime":"2026-08-06 23:58","pubTimestamp":1786031880,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TVTX/analyst-ratings","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","FFTY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657446634","title":"Wedbush Sticks to Their Buy Rating for Travere Therapeutics (TVTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2657446634","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657446634?lang=en_us&edition=fundamental","pubTime":"2026-08-06 20:57","pubTimestamp":1786021075,"startTime":"0","endTime":"0","summary":"Wedbush analyst Laura Chico maintained a Buy rating on Travere Therapeutics today and set a price target of $75.00. Chico covers the Healthcare sec...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wedbush-sticks-to-their-buy-rating-for-travere-therapeutics-tvtx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wedbush-sticks-to-their-buy-rating-for-travere-therapeutics-tvtx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FFTY","TVTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657502347","title":"Regulatory Uncertainty Threatens Travere Therapeutics’ Cross-Border Deals and Partnerships","url":"https://stock-news.laohu8.com/highlight/detail?id=2657502347","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657502347?lang=en_us&edition=fundamental","pubTime":"2026-08-06 14:01","pubTimestamp":1785996100,"startTime":"0","endTime":"0","summary":"Travere Therapeutics, Inc. (TVTX) has disclosed a new risk, in the Corporate Activity and Growth category. Travere Therapeutics, Inc. faces growing...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/regulatory-uncertainty-threatens-travere-therapeutics-cross-border-deals-and-partnerships?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/regulatory-uncertainty-threatens-travere-therapeutics-cross-border-deals-and-partnerships?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LFSC","BK4139","FFTY","LENZ","TVTX","BK4539","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657780755","title":"Does FILSPARI-Driven Revenue Growth And Wider Losses Change The Bull Case For Travere Therapeutics (TVTX)?","url":"https://stock-news.laohu8.com/highlight/detail?id=2657780755","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657780755?lang=en_us&edition=fundamental","pubTime":"2026-08-06 02:28","pubTimestamp":1785954531,"startTime":"0","endTime":"0","summary":"Travere Therapeutics reported past second-quarter 2026 results with revenue rising to US$169.58 million from US$114.45 million a year earlier, while net loss increased to US$34.8 million and basic loss per share widened to US$0.37.\nThe quarter highlighted record demand for FILSPARI in IgA nephropathy and an early FSGS launch, alongside pipeline expansion through the in-licensing of civorebrutinib and progress of the pegtibatinase HARMONY program.\nAgainst this backdrop of strong...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-tvtx/travere-therapeutics/news/does-filspari-driven-revenue-growth-and-wider-losses-change","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-tvtx/travere-therapeutics/news/does-filspari-driven-revenue-growth-and-wider-losses-change","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["FFTY","TVTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657526575","title":"Travere Therapeutics is Maintained at Outperform by Evercore ISI Group","url":"https://stock-news.laohu8.com/highlight/detail?id=2657526575","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657526575?lang=en_us&edition=fundamental","pubTime":"2026-08-05 23:47","pubTimestamp":1785944820,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TVTX/analyst-ratings","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FFTY","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657523025","title":"Sterling Infrastructure is Maintained at Overweight by Keybanc","url":"https://stock-news.laohu8.com/highlight/detail?id=2657523025","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657523025?lang=en_us&edition=fundamental","pubTime":"2026-08-05 22:55","pubTimestamp":1785941700,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/STRL/analyst-ratings","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FFTY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657544925","title":"Vertiv Holdings Co's (NYSE:VRT) Earnings May Just Be The Starting Point","url":"https://stock-news.laohu8.com/highlight/detail?id=2657544925","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657544925?lang=en_us&edition=fundamental","pubTime":"2026-08-05 19:57","pubTimestamp":1785931068,"startTime":"0","endTime":"0","summary":"Vertiv Holdings Co ( NYSE:VRT ) just reported healthy earnings but the stock price didn't move much. Our analysis...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/3051000-choice2-main-header/1585186647175","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/3051000-choice2-main-header/1585186647175"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/capital-goods/nyse-vrt/vertiv-holdings-co/news/vertiv-holdings-cos-nysevrt-earnings-may-just-be-the-startin-1","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/capital-goods/nyse-vrt/vertiv-holdings-co/news/vertiv-holdings-cos-nysevrt-earnings-may-just-be-the-startin-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["VRT","FFTY","NYSE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657854987","title":"Travere Therapeutics price target raised to $62 from $43 at Stifel","url":"https://stock-news.laohu8.com/highlight/detail?id=2657854987","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657854987?lang=en_us&edition=fundamental","pubTime":"2026-08-05 19:17","pubTimestamp":1785928672,"startTime":"0","endTime":"0","summary":"Stifel raised the firm’s price target on Travere Therapeutics (TVTX) to $62 from $43 and keeps a Hold rating on the shares. Published first on TheF...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/travere-therapeutics-price-target-raised-to-62-from-43-at-stifel-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/travere-therapeutics-price-target-raised-to-62-from-43-at-stifel-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FFTY","SF","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657516665","title":"Travere Therapeutics (TVTX) Stock Rallies Over 13% After Hours: Here's What Is Going On","url":"https://stock-news.laohu8.com/highlight/detail?id=2657516665","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657516665?lang=en_us&edition=fundamental","pubTime":"2026-08-05 15:16","pubTimestamp":1785914176,"startTime":"0","endTime":"0","summary":"Travere Therapeutics shares surged 13.44% after hours as strong revenue growth and FILSPARI sales gains outweighed earnings concerns.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/equities/26/08/60938354/travere-therapeutics-shares-surge-after-hours-on-revenue-growth","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BETZ","ODDZ","LFSC","BK4139","FFTY","TVTX","ODDS","RSI","BK4150"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657569395","title":"Travere Therapeutics Q2 Adj. EPS $(0.10) Beats $(0.14) Estimate, Sales $169.584M Beat $159.589M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2657569395","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657569395?lang=en_us&edition=fundamental","pubTime":"2026-08-05 04:02","pubTimestamp":1785873732,"startTime":"0","endTime":"0","summary":"Travere Therapeutics Q2 Adj. EPS $(0.10) Beats $(0.14) Estimate, Sales $169.584M Beat $159.589M Estimate","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/quote/TVTX","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FFTY","LENZ"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":5,"totalSize":200,"code":"91000000","status":"200"}]}}